Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006097
Status:
COMPLETED
Last Update Posted:
2010-09-22
First Post:
2000-08-03
Brief Title:
Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia
Sponsor:
Boston Medical Center
Organization:
Boston Medical Center
Study Overview
Official Title:
CC-1088 Therapy for Chronic Lymphocytic Leukemia A Phase III Trial
Status:
COMPLETED
Status Verified Date:
2001-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
PURPOSE Phase III trial to study the effectiveness of CC-1088 in treating patients who have chronic lymphocytic leukemia that has not responded to previous therapy
PURPOSE Phase III trial to study the effectiveness of CC-1088 in treating patients who have chronic lymphocytic leukemia that has not responded to previous therapy
Detailed Description:
OBJECTIVES I Determine the toxicity of CC-1088 in patients with refractory progressive B-cell chronic lymphocytic leukemia II Determine the response rate to this treatment in these patients
OUTLINE Patients receive oral CC-1088 three times a day for 28 days Treatment continues in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL A total of 11-20 patients will be accrued for this study
OUTLINE Patients receive oral CC-1088 three times a day for 28 days Treatment continues in the absence of disease progression or unacceptable toxicity
PROJECTED ACCRUAL A total of 11-20 patients will be accrued for this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-V00-1603 | None | None | None |
| BUMC-5092 | None | None | None |